title: [Cognitive evaluation during brain radiotherapy in adults: a simple assessment is possible].
abstract: Brain irradiation can be used for the treatment of cancers in different protocols: focal radiotherapy, whole brain radiotherapy, with or without additive dose on the tumour. Different modalities (conformational, stereotactic radiosurgery) can be used for curative or prophylactic treatment. Brain radiotherapy leads to cognitive deterioration with subcortical profile. This cognitive deterioration can be associated to radiation-induced leukoencephalopathy on brain MRI. Taking into account radiation induced cognitive troubles is becoming more important with the prolonged survival allowed by treatment improvement. Concerning low-grade gliomas, radiation-induced cognitive troubles appear about 6 years after treatment and occur earlier when the fraction dose is important. Primitive cerebral lymphoma treatment can induce cognitive troubles in 25 to 30% surviving patients. These deficits are more frequent in elderly patients, leading to radiotherapy delay in those patients. Patients treated for brain metastasis often have cognitive impairment before radiotherapy (until 66%), this pretreatment impairment is related to global survival. The use of conformational radiation therapy, particularly with hippocampal sparing is conceptually interesting but has not proved its efficiency for cognitive preservation in clinical trials yet. Stereotactic radiation therapy could be an interesting compromise between metastatic tumoral volume reduction and cognitive preservation. Taking care of radiotherapy induced cognitive troubles is a challenge. Before considering its treatment and prevention, we need to elaborate a way of detecting them using a reliable and easy way. CSCT, a computerized test whose execution needs 90 seconds, could be used before treatment and during the clinical follow-up by the patient's oncologist or radiotherapist. If the patient's performance reduces, he can be oriented to a neurologist in order to perform fuller evaluation of its cognitive capacities and be treated if necessary.
authors.affiliation: Service de neurologie, hôpital d'instruction des armées, 74, boulevard de Port-Royal, 75005 Paris, France. Electronic address: herve.taillia@santarm.fr.
authors.forename: H
authors.initials: H
authors.lastname: Taillia
authors.forename: F
authors.initials: F
authors.lastname: Bompaire
authors.forename: J
authors.initials: J
authors.lastname: Jacob
authors.forename: G
authors.initials: G
authors.lastname: Noël
mesh_terms: D001932:Brain Neoplasms / Q000532:radiotherapy* / Q000556:secondary / Q000601:surgery; D003072:Cognition Disorders / Q000175:diagnosis* / Q000209:etiology* / Q000517:prevention & control; D016371:Cranial Irradiation; D006801:Humans; D009483:Neuropsychological Tests; D016634:Radiosurgery; D011878:Radiotherapy / Q000009:adverse effects
keywords: Adverse effects; Cerebral metastases; Cerebral radiotherapy; Cognition; Cognitive assessment; Effets secondaires; Gliome de bas grade; Low-grade glioma; Métastases cérébrales; Radiothérapie cérébrale; Tests neuropsychologiques